These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 13166700)

  • 1. [Hypoglycemic action of insulin-zinc-globin product].
    SPASOWICZ T
    Pol Tyg Lek (Wars); 1954 Jan; 9(4):121-2. PubMed ID: 13166700
    [No Abstract]   [Full Text] [Related]  

  • 2. A [meso-tetrakis(4-sulfonatophenyl)porphyrinato]zinc(ii) complex as an oral therapeutic for the treatment of type 2 diabetic KKA(y) mice.
    Saha TK; Yoshikawa Y; Sakurai H
    ChemMedChem; 2007 Feb; 2(2):218-25. PubMed ID: 17245806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice.
    Wu ZH; Ping QN; Wei Y; Lai JM
    Acta Pharmacol Sin; 2004 Jul; 25(7):966-72. PubMed ID: 15210073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lente insulin, clinical study of a new insulin zinc preparation of prolonged action.
    HOLCOMB B; PAGE OC; STEPHENS JW
    Northwest Med; 1954 Mar; 53(3):239-41. PubMed ID: 13154705
    [No Abstract]   [Full Text] [Related]  

  • 5. Local insulin-zinc injection accelerates skin donor site wound healing.
    Zhang XJ; Wu X; Wolf SE; Hawkins HK; Chinkes DL; Wolfe RR
    J Surg Res; 2007 Sep; 142(1):90-6. PubMed ID: 17597156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First inhaled insulin product approved.
    FDA Consum; 2006; 40(2):28-9. PubMed ID: 16671198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern of insulin delivery affects hepatic insulin sensitizing substance (HISS) action and insulin resistance.
    Reid MA; Lautt WW
    Can J Physiol Pharmacol; 2004 Dec; 82(12):1068-74. PubMed ID: 15644948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged antidiabetic effect of zinc-crystallized insulin loaded glycol chitosan nanoparticles in type 1 diabetic rats.
    Jo HG; Min KH; Nam TH; Na SJ; Park JH; Jeong SY
    Arch Pharm Res; 2008 Jul; 31(7):918-23. PubMed ID: 18704336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental determination of the prolonged effects of preparations of clupeine zinc insulin and salmine zinc insulin].
    HERBAIN M
    Ann Pharm Fr; 1954 Feb; 12(2):121-5. PubMed ID: 13171731
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intelligent polymeric systems for glucose-responsive insulin delivery].
    Qu J; Chu L; Li Y; Chen W; Zheng C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Dec; 21(6):1028-30. PubMed ID: 15646358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel insulin derivative chemically modified with dehydrocholic acid: synthesis, characterization and biological activity.
    Huang T; Huang K
    Biotechnol Appl Biochem; 2005 Aug; 42(Pt 1):47-56. PubMed ID: 15612881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New insulin with uniform action. Hazards of blood sugar variations minimized].
    MMW Fortschr Med; 2003 Oct; 145(40):55. PubMed ID: 14603609
    [No Abstract]   [Full Text] [Related]  

  • 13. Glargine and protamine zinc insulin have a longer duration of action and result in lower mean daily glucose concentrations than lente insulin in healthy cats.
    Marshall RD; Rand JS; Morton JM
    J Vet Pharmacol Ther; 2008 Jun; 31(3):205-12. PubMed ID: 18471141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transitioning and adjusting insulin analog therapy in elderly patients.
    Bray B
    Consult Pharm; 2008 Apr; 23 Suppl B():17-23. PubMed ID: 18540789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization and in vivo evaluation of an oral dual controlled-release tablet dosage form of insulin and duck ovomucoid.
    Agarwal V; Nazzal S; Khan MA
    Pharm Dev Technol; 2008; 13(4):291-8. PubMed ID: 18618331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New tools 2004.
    Fennell D; Nakamoto M
    Diabetes Self Manag; 2004; 21(6):15-8, 21-3. PubMed ID: 15688463
    [No Abstract]   [Full Text] [Related]  

  • 17. Ability of GHTD-amide and analogs to enhance insulin activity through zinc chelation and dispersal of insulin oligomers.
    Paule SG; Nikolovski B; Ludeman J; Gray RE; Spiccia L; Zimmet PZ; Myers MA
    Peptides; 2009 Jun; 30(6):1088-97. PubMed ID: 19463741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing the risk of injuries to staff from insulin pens.
    Edwards C; Metcalfe L; Allan J; Haynes A
    Nurs Times; 2005 Jun 21-27; 101(25):34-6. PubMed ID: 15997948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should I consider using an insulin pump to take insulin for type 2 diabetes?
    Johns Hopkins Med Lett Health After 50; 2004 Aug; 17(6):8. PubMed ID: 15281175
    [No Abstract]   [Full Text] [Related]  

  • 20. Biopharmaceutical characterisation of insulin and recombinant human growth hormone loaded lipid submicron particles produced by supercritical gas micro-atomisation.
    Salmaso S; Bersani S; Elvassore N; Bertucco A; Caliceti P
    Int J Pharm; 2009 Sep; 379(1):51-8. PubMed ID: 19545616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.